Association between IRS-2 G1057D polymorphism and risk of gastric cancer

doi:10.4251/wjgo.v4.i1.9

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3296)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

385

HTML

2604

Figures (1-1)

163

Tables (1-4)

144

Sum=3296

Jan 15, 2012 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Oncol. Jan 15, 2012; 4(1): 9-15
Published online Jan 15, 2012. doi: 10.4251/wjgo.v4.i1.9

Open in New Tab Full Size Figure Download Figure

Figure 1 Genotypes of insulin receptor substrate-2 G1057D confirmed by polymerase chain reaction-restriction fragment length polymorphism assay and direct sequencing. A: Representatives of genotypes by polymerase chain reaction-restriction fragment length polymorphism assay. L4, L8 were identified as DD; L1, L3 and L7 were identified as GD; L2, L5 and L6 were identified as GG; B, C and D: Representatives of GG, GD, DD genotypes by direct DNA sequencing respectively.

Citation: Zhao XM, Chen J, Yang L, Luo X, Xu LL, Liu DX, Zhai SL, Li P, Wang XR. Association between IRS-2 G1057D polymorphism and risk of gastric cancer. World J Gastrointest Oncol 2012; 4(1): 9-15
URL: https://www.wjgnet.com/1948-5204/full/v4/i1/9.htm
DOI: https://dx.doi.org/10.4251/wjgo.v4.i1.9